Trial
NCT03868943
Solriamfetol in Improving Sleep in Patients With Grade II-IV Glioma
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Wake Forest University Health Sciences
Collaborators
National Cancer Institute (NCI)
Condition
Glioma
Intervention
Soliramfetol
Why stopped
Axsome has conducted a review of the ongoing IST program and are unable to continue supporting this study
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-10-21